🎉 M&A multiples are live!
Check it out!

Vimab Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Vimab Group and similar public comparables like Business Online, Bluebik Group, and RPMGlobal.

Vimab Group Overview

About Vimab Group

Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.


Founded

1983

HQ

Sweden
Employees

174

Website

vimabgroup.com

Financials

Last FY Revenue $33.4M

Last FY EBITDA -$1.5M

EV

$27.1M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Vimab Group Financials

In the most recent fiscal year, Vimab Group achieved revenue of $33.4M and an EBITDA of -$1.5M.

Vimab Group expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Vimab Group valuation multiples based on analyst estimates

Vimab Group P&L

NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $33.4M XXX XXX XXX
Gross Profit XXX $26.2M XXX XXX XXX
Gross Margin XXX 79% XXX XXX XXX
EBITDA XXX -$1.5M XXX XXX XXX
EBITDA Margin XXX -5% XXX XXX XXX
EBIT XXX -$8.2M XXX XXX XXX
EBIT Margin XXX -25% XXX XXX XXX
Net Profit XXX -$7.9M XXX XXX XXX
Net Margin XXX -24% XXX XXX XXX
Net Debt XXX $5.5M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Vimab Group Stock Performance

As of May 30, 2025, Vimab Group's stock price is SEK 8 (or $1).

Vimab Group has current market cap of SEK 191M (or $19.7M), and EV of SEK 263M (or $27.1M).

See Vimab Group trading valuation data

Vimab Group Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$27.1M $19.7M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Vimab Group Valuation Multiples

As of May 30, 2025, Vimab Group has market cap of $19.7M and EV of $27.1M.

Vimab Group's trades at 0.8x EV/Revenue multiple, and -17.6x EV/EBITDA.

Equity research analysts estimate Vimab Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Vimab Group's P/E ratio is not available.

See valuation multiples for Vimab Group and 12K+ public comps

Vimab Group Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $19.7M XXX $19.7M XXX XXX XXX
EV (current) $27.1M XXX $27.1M XXX XXX XXX
EV/Revenue n/a XXX 0.8x XXX XXX XXX
EV/EBITDA n/a XXX -17.6x XXX XXX XXX
EV/EBIT n/a XXX -3.3x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX -2.5x XXX XXX XXX
EV/FCF n/a XXX -32.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Vimab Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Vimab Group Margins & Growth Rates

Vimab Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Vimab Group's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Vimab Group's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Vimab Group and other 12K+ public comps

Vimab Group Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX -5% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.2M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 103% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Vimab Group Public Comps

See public comps and valuation multiples for Business Consulting comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Almunda Professionals XXX XXX XXX XXX XXX XXX
Appen XXX XXX XXX XXX XXX XXX
RPMGlobal XXX XXX XXX XXX XXX XXX
Bluebik Group XXX XXX XXX XXX XXX XXX
Business Online XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Vimab Group M&A and Investment Activity

Vimab Group acquired  XXX companies to date.

Last acquisition by Vimab Group was  XXXXXXXX, XXXXX XXXXX XXXXXX . Vimab Group acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Vimab Group

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Vimab Group

When was Vimab Group founded? Vimab Group was founded in 1983.
Where is Vimab Group headquartered? Vimab Group is headquartered in Sweden.
How many employees does Vimab Group have? As of today, Vimab Group has 174 employees.
Is Vimab Group publicy listed? Yes, Vimab Group is a public company listed on STO.
What is the stock symbol of Vimab Group? Vimab Group trades under VIMAB ticker.
When did Vimab Group go public? Vimab Group went public in 2015.
Who are competitors of Vimab Group? Similar companies to Vimab Group include e.g. Almunda Professionals, Appen, RPMGlobal, Bluebik Group.
What is the current market cap of Vimab Group? Vimab Group's current market cap is $19.7M
Is Vimab Group profitable? Yes, Vimab Group is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.